Reaction

Weight Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,364 reports · 48 co-occurring drugs

As of the last recalculation, Weight Abnormal appears in 2,364 FAERS reports alongside 48 co-occurring drug terms. The strongest observed disproportionality signal is CANNABIDIOL (PRR 51.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Cannabidiol	130	51.7	52.0
Teduglutide	25	16.5	16.5
Diphenhydramine Hydrochloride Capsule, Liquid Filled	30	12.5	12.5
Rotigotine	16	9.8	9.8
Trimethoprim	11	8.2	8.3
Asenapine Maleate	8	8.2	8.2
Elexacaftor, Tezacaftor, And Ivacaftor	11	7.8	7.8
Pancrelipase	32	7.4	7.4
Sacubitril And Valsartan	90	7.1	7.1
Riociguat	25	6.8	6.8
Lanreotide Acetate	6	6.8	6.8
Lumacaftor And Ivacaftor	6	6.2	6.2
Tobramycin	16	5.9	5.9
Tobramycin Solution	8	5.9	5.9
Tobramycin Sulfate	8	5.7	5.7
Dornase Alfa	12	5.4	5.4
Emicizumab	7	5.0	5.0
Ziprasidone Mesylate	8	5.0	5.0
Selexipag	14	4.8	4.8
Rasagiline Mesylate	6	4.8	4.8
Macitentan	36	4.6	4.6
Desvenlafaxine Succinate	14	4.6	4.6
Asfotase Alfa	5	4.4	4.4
Fam-Trastuzumab Deruxtecan-Nxki	5	4.4	4.4
Cortisone Acetate	6	4.3	4.3
Lurasidone Hydrochloride	10	4.2	4.2
Bosutinib	4	3.9	3.9
Brivaracetam	4	3.9	3.9
Ravulizumab	6	3.9	3.9
Treprostinil	54	3.9	3.9
Agalsidase Beta	4	3.8	3.8
Brexpiprazole	7	3.7	3.7
Mometasone Furoate And Formoterol Fumarate Dihydrate	6	3.4	3.4
Olaparib	8	3.4	3.4
Relugolix	9	3.4	3.4
Ozanimod Hydrochloride	3	3.2	3.2
Axitinib	7	3.2	3.2
Tafamidis	4	3.0	3.0
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	10	2.8	2.8
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	3	2.6	2.6
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	5	2.4	2.4
Vigabatrin	4	2.4	2.4
Etonogestrel	12	2.2	2.2
Cabozantinib	12	2.2	2.2
Osimertinib	7	1.9	1.9
Dulaglutide	17	1.7	1.7
Dupilumab	72	1.3	1.3
Voxelotor	3	1.2	1.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.